HENRIQUE BARBOSA RIBEIRO
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
7 resultados
Resultados de Busca
Agora exibindo 1 - 7 de 7
conferenceObject Predictors of 30-Day Outcomes After TAVR in Low-Flow, Low-Gradient Aortic Stenosis(2018) ROSA, Vitor E. E.; ECHEVERRI, Dario; SZTEJFMAN, Matias; JAIKEL, Luis A.; DAGER, Antonio; MALUENDA, Gabriel; ABUD, Marcelo; DALMONTE, Anibal; FUCHS, Felipe C.; SARMENTO-LEITE, Rogerio; PRATES, Paulo; ABIZAID, Alexandre; SIQUEIRA, Dimytri; CHARRY, Pablo; CHAUVET, Alejandro A.; TARASOUTCHI, Flavio; CURA, Fernando; RIBEIRO, Henrique B.- Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement Comprehensive Midterm Evaluation of Valve-in-Valve and Valve-in-Ring Implantation From the VIVID Registry(2021) SIMONATO, Matheus; WHISENANT, Brian; RIBEIRO, Henrique Barbosa; WEBB, John G.; KORNOWSKI, Ran; GUERRERO, Mayra; WIJEYSUNDERA, Harindra; SONDERGAARD, Lars; BACKER, Ole De; VILLABLANCA, Pedro; RIHAL, Charanjit; ELEID, Mackram; KEMPFERT, Jorg; UNBEHAUN, Axel; ERLEBACH, Magdalena; CASSELMAN, Filip; ADAM, Matti; MONTORFANO, Matteo; ANCONA, Marco; SAIA, Francesco; UBBEN, Timm; MEINCKE, Felix; NAPODANO, Massimo; CODNER, Pablo; SCHOFER, Joachim; PELLETIER, Marc; CHEUNG, Anson; SHUVY, Mony; PALMA, Jose Honorio; GAIA, Diego Felipe; DUNCAN, Alison; HILDICK-SMITH, David; VEULEMANS, Verena; SINNING, Jan-Malte; ARBEL, Yaron; TESTA, Luca; WEGER, Arend de; ELTCHANINOFF, Helene; HEMERY, Thibault; LANDES, Uri; TCHETCHE, Didier; DUMONTEIL, Nicolas; RODES-CABAU, Josep; KIM, Won-Keun; SPARGIAS, Konstantinos; KOURKOVELI, Panagiota; BEN-YEHUDA, Ori; TELES, Rui Campante; BARBANTI, Marco; FIORINA, Claudia; THUKKANI, Arun; MACKENSEN, G. Burkhard; JONES, Noah; PRESBITERO, Patrizia; PETRONIO, Anna Sonia; ALLALI, Abdelhakim; CHAMPAGNAC, Didier; BLEIZIFFER, Sabine; RUDOLPH, Tanja; IADANZA, Alessandro; SALIZZONI, Stefano; AGRIFOGLIO, Marco; NOMBELA-FRANCO, Luis; BONAROS, Nikolaos; KASS, Malek; BRUSCHI, Giuseppe; AMABILE, Nicolas; CHHATRIWALLA, Adnan; MESSINA, Antonio; HIRJI, Sameer A.; ANDREAS, Martin; WELSH, Robert; SCHOELS, Wolfgang; HELLIG, Farrel; WINDECKER, Stephan; STORTECKY, Stefan; MAISANO, Francesco; STONE, Gregg W.; DVIR, DannyBackground: Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical reoperation in patients with recurrent mitral valve failure after previous surgical valve repair or replacement. Our aim was to perform a large-scale analysis examining midterm outcomes after mitral ViV and ViR. Methods: Patients undergoing mitral ViV and ViR were enrolled in the Valve-in-Valve International Data Registry. Cases were performed between March 2006 and March 2020. Clinical endpoints are reported according to the Mitral Valve Academic Research Consortium (MVARC) definitions. Significant residual mitral stenosis (MS) was defined as mean gradient >= 10 mm Hg and significant residual mitral regurgitation (MR) as >= moderate. Results: A total of 1079 patients (857 ViV, 222 ViR; mean age 73.5 +/- 12.5 years; 40.8% male) from 90 centers were included. Median STS-PROM score 8.6%; median clinical follow-up 492 days (interquartile range, 76-996); median echocardiographic follow-up for patients that survived 1 year was 772.5 days (interquartile range, 510-1211.75). Four-year Kaplan-Meier survival rate was 62.5% in ViV versus 49.5% for ViR (P<0.001). Mean gradient across the mitral valve postprocedure was 5.7 +/- 2.8 mm Hg (>= 5 mm Hg; 61.4% of patients). Significant residual MS occurred in 8.2% of the ViV and 12.0% of the ViR patients (P=0.09). Significant residual MR was more common in ViR patients (16.6% versus 3.1%; P<0.001) and was associated with lower survival at 4 years (35.1% versus 61.6%; P=0.02). The rates of Mitral Valve Academic Research Consortium-defined device success were low for both procedures (39.4% total; 32.0% ViR versus 41.3% ViV; P=0.01), mostly related to having postprocedural mean gradient >= 5 mm Hg. Correlates for residual MS were smaller true internal diameter, younger age, and larger body mass index. The only correlate for residual MR was ViR. Significant residual MS (subhazard ratio, 4.67; 95% CI, 1.74-12.56; P=0.002) and significant residual MR (subhazard ratio, 7.88; 95% CI, 2.88-21.53; P<0.001) were both independently associated with repeat mitral valve replacement. Conclusions: Significant residual MS and/or MR were not infrequent after mitral ViV and ViR procedures and were both associated with a need for repeat valve replacement. Strategies to improve postprocedural hemodynamics in mitral ViV and ViR should be further explored.
conferenceObject Short- and Long-term Outcomes After Surgical Aortic Valve Replacement in Patients With Classical Low-flow, Low-gradient Aortic Stenosis(2019) ROSA, Vitor E.; RIBEIRO, Henrique B.; SAMPAIO, Roney O.; MORAIS, Thamara C.; ROSA, Marcela E.; SANTIS, Antonio S. De; FERNANDES, Joao Ricardo C.; SPINA, Guilherme S.; VIEIRA, Marcelo L.; POMERANTZEFF, Pablo M.; ROCHITTE, Carlos E.; MATHIAS JR., Wilson; TARASOUTCHI, Flavio- Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial(2024) RODES-CABAU, Josep; RIBEIRO, Henrique Barbosa; MOHAMMADI, Siamak; SERRA, Vicenc; AL-ATASSI, Talal; INIGUEZ, Andres; VILALTA, Victoria; NOMBELA-FRANCO, Luis; SANCHEZ, Jose Ignacio Saez de Ibarra; AUFFRET, Vincent; FORCILLO, Jessica; CONRADI, Lenard; URENA, Marina; MORIS, Cesar; MUNOZ-GARCIA, Antonio; PARADIS, Jean-Michel; DUMONT, Eric; KALAVROUZIOTIS, Dimitri; POMERANTZEFF, Pablo Maria; ROSA, Vitor Emer Egypto; LOPES, Mariana Pezzute; SUREDA, Carles; DIAZ, Victor Alfonso Jimenez; GIULIANI, Carlos; AVVEDIMENTO, Marisa; PELLETIER-BEAUMONT, Emilie; PIBAROT, PhilippeBACKGROUND: The optimal treatment in patients with severe aortic stenosis and small aortic annulus (SAA) remains to be determined. This study aimed to compare the hemodynamic and clinical outcomes between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with a SAA. METHODS: This prospective multicenter international randomized trial was performed in 15 university hospitals. Participants were 151 patients with severe aortic stenosis and SAA (mean diameter <23 mm) randomized (1:1) to TAVR (n=77) versus SAVR (n=74). The primary outcome was impaired valve hemodynamics (ie, severe prosthesis patient mismatch or moderate-severe aortic regurgitation) at 60 days as evaluated by Doppler echocardiography and analyzed in a central echocardiography core laboratory. Clinical events were secondary outcomes. RESULTS: The mean age of the participants was 75.5 +/- 5.1 years, with 140 (93%) women, a median Society of Thoracic Surgeons predicted risk of mortality of 2.50% (interquartile range, 1.67%-3.28%), and a median annulus diameter of 21.1 mm (interquartile range, 20.4-22.0 mm). There were no differences between groups in the rate of severe prosthesis patient mismatch (TAVR, 4 [5.6%]; SAVR, 7 [10.3%]; P=0.30) and moderate-severe aortic regurgitation (none in both groups). No differences were found between groups in mortality rate (TAVR, 1 [1.3%]; SAVR, 1 [1.4%]; P=1.00) and stroke (TAVR, 0; SAVR, 2 [2.7%]; P=0.24) at 30 days. After a median follow-up of 2 (interquartile range, 1-4) years, there were no differences between groups in mortality rate (TAVR, 7 [9.1%]; SAVR, 6 [8.1%]; P=0.89), stroke (TAVR, 3 [3.9%]; SAVR, 3 [4.1%]; P=0.95), and cardiac hospitalization (TAVR, 15 [19.5%]; SAVR, 15 [20.3%]; P=0.80). CONCLUSIONS: In patients with severe aortic stenosis and SAA (women in the majority), there was no evidence of superiority of contemporary TAVR versus SAVR in valve hemodynamic results. After a median follow-up of 2 years, there were no differences in clinical outcomes between groups. These findings suggest that the 2 therapies represent a valid alternative for treating patients with severe aortic stenosis and SAA, and treatment selection should likely be individualized according to baseline characteristics, additional anatomical risk factors, and patient preference. However, the results of this study should be interpreted with caution because of the limited sample size leading to an underpowered study, and need to be confirmed in future larger studies.
- Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement(2020) VAL, David del; LINKE, Axel; ABDEL-WAHAB, Mohamed; LATIB, Azeem; IHLEMANN, Nikolaj; URENA, Marina; WON-KEUN, Kim; HUSSER, Oliver; HERRMANN, Howard C.; NOMBELA-FRANCO, Luis; CHEEMA, Asim N.; BRETON, Herve Le; STORTECKY, Stefan; BARTORELLI, Antonio L.; SINNING, Jan Malte; AMAT-SANTOS, Ignacio; MUNOZ-GARCIA, Antonio; LERAKIS, Stamatios; GUTIERREZ-IBANEZ, Enrique; LANDT, Martin; TCHETCHE, Didier; TESTA, Luca; ELTCHANINOFF, Helene; LIVI, Ugolino; CASTILLO, Juan Carlos; CHAKRAVARTY, Tarun; WEBB, John G. j; BARBANTI, Marco; KODALI, Susheel; BRITO JR., Fabio S. de; RIBEIRO, Henrique Barbosa; MICELI, Antonio; FIORINA, Claudia; DATO, Guglielmo Mario Actis; ROSATO, Francesco; SERRA, Vicenc; MASSON, Jean-Bernard; WIJEYSUNDERA, Harindra C.; MANGIONE, Jose A.; FERREIRA, Maria-Cristina; LIMA, Valter Correa; COLAFRANCESCHI, Alexandre Siciliano; ABIZAID, Alexandre; MARINO, Marcos Antonio; ESTEVES, Vinicius; ANDREA, Julio C. M.; HIMBERT, Dominique; PELLEGRINI, Costanza; AUFFRET, Vincent; OLIVARES, Paolo; NIETLISPACH, Fabian; PILGRIM, Thomas; DURAND, Eric; LISKO, John; MAKKAR, Raj; ALKHODAIR, Abdullah; SONDERGAARD, Lars; MANGNER, Norman; CRUSIUS, Lisa; HOLZHEY, David; REGUEIRO, Ander; RODES-CABAU, Josep
conferenceObject Predictors of 1-Year Mortality After Surgical Aortic Valve Replacement in Patients With Classical Low-Flow, Low-Gradient Aortic Stenosis.(2018) ROSA, Vitor E. E.; RIBEIRO, Henrique B.; SAMPAIO, Roney O.; MORAIS, Thamara C.; ROSA, Marcela E. E.; SANTIS, Antonio S. A. I Antonio de; FERNANDES, Joao Ricardo C.; VIEIRA, Marcelo L. C.; POMERANTZEFF, Pablo M. A.; ROCHITTE, Carlos E.; JR, Wilson Mathias; TARASOUTCHI, FlavioconferenceObject Very Long-term Mortality After St Elevation Myocardial Infarction (stemi) Complicated By Cardiogenic Shock(2021) KANHOUCHE, Gabriel; NICOLAU, Jose; DALCOQUIO, Talia Falcao; MARCHI, Mauricio Felippi de Sa; GIRALDEZ, Roberto R.; FURTADO, Remo; BARACIOLI, Luciano; KALIL FILHO, Roberto; BRITO JUNIOR, Fabio de; ABIZAID, Alexandre; RIBEIRO, Henrique